Smart ring maker Oura abruptly postponed its U.S. initial public offering, shelving plans to raise up to $2.2 billion on the Nasdaq amid market volatility, despite reporting surging revenue, growing profits, and 5.7 million paid subscribers.
The wearable technology sector received an unexpected jolt when Oura postponed its U.S. initial public offering on Tuesday, backing away from what was expected to be one of the autumn season’s blockbuster market debuts. The San Francisco-based company, which makes sensor-laden smart rings worn by celebrities including Coco Gauff and Lady Gaga, had planned to price 50 million shares between $40 and $44 each and begin trading on the Nasdaq under the ticker symbol OURA.
Instead, the offering was shelved at the eleventh hour. The firm pointed squarely to uncertainty in the IPO market
as the primary driver behind the halt, choosing to delay its flotation despite strong demand
for its health-tracking hardware.
Oura Targets $15.62 Billion Valuation Before Market Jitters Halt Nasdaq Listing
At the top of its indicated price range, Oura and its existing investors aimed to raise as much as $2.2 billion, which would have given the enterprise a fully diluted valuation of $15.62 billion. The offering was slated as the first major fall market U.S. IPO following the traditional summer lull, functioning as an important barometer for investor appetite toward high-growth consumer technology firms.
Initial indicators suggested heavy participation. Weight-loss drugmaker Eli Lilly had signaled interest in buying up to $100 million in shares, while investment firm Dragoneer considered purchasing up to $300 million worth. Reports also indicated the offering was roughly four times oversubscribed. Yet macroeconomic pressures intervened as bond yields spiked, concerns mounted over Federal Reserve interest rate policy, and geopolitical turmoil clouded investor sentiment across equities.
“What is now clear is we are in a very different IPO market to the one we envisaged just a few weeks ago.”
Samuel Kerr, global head of equity capital markets at Mergermarket
Samuel Kerr, global head of equity capital markets at Mergermarket, added that even strong businesses with spectacular economics will face greater scrutiny.
Oura was not alone in hitting the brakes. Nuclear services company Holtec International and Bamboo Insurance also suspended their planned U.S. market listings during the same period, citing an unusual confluence of rising energy costs, global trade tensions, and inflation worries.
Financial Growth Propels Oura Toward Recurring Revenue Expansion
Behind the postponed share sale lies a business model that has scaled rapidly over the last several years. Founded in Finland in 2013, Oura reached an $11 billion valuation in a late-stage funding round last year led by Fidelity, doubling its valuation from less than a year prior. Its hardware targets a distinct niche between traditional fitness trackers and smartwatches, offering a screen-free form factor that monitors heart health, stress levels, body temperature, and sleep patterns.
Financial disclosures filed ahead of the aborted listing revealed a thriving operation. For the full financial year ending September 30, 2025, Oura reported a pre-tax profit of nearly $61 million on sales of $907.9 million, marking a significant jump from the pre-tax profit recorded the previous year. Its most recent figures for the nine months leading up to June 30 showed revenue surging roughly 74 percent year-over-year on sales of $1.21 billion.
- Revenue for the nine months ended June 30 surged roughly 74 percent year-over-year to $1.21 billion.
- Subscriptions, which cost $6 a month for advanced health insights, carry an 89% gross margin and accounted for roughly 20% of total sales in the latest period.
Chief Executive Tom Hale Weighs Timing for Market Debut
While the delay postpones liquidity for existing shareholders—such as early investor Forerunner Ventures, which had planned to sell its entire stake to net substantial returns—company leadership emphasized that the firm is under no immediate financial pressure to rush its market debut.
“Our mission is to empower people to live healthier, longer, and an IPO is just one step in our journey. We aim to deliver an extraordinary IPO for our employees and investors and we have the luxury of choosing our moment. In the meantime, we will execute against the opportunities ahead.”
Tom Hale, CEO
The company intended to direct the majority of its IPO proceeds toward covering employee-related tax obligations on vested share grants rather than drawing down its existing cash reserves, which stood at $372 million at the end of June. Company executives noted that the market launch of its latest hardware iteration, the Oura Ring 5, has received an exceptionally strong reception, helping drive subscriber numbers higher even as the macroeconomic climate forces high-growth tech firms to recalibrate their public market timelines.